Report Description

India ceftriaxone market is forecasted to grow at a steady pace during the forecast period. Ceftriaxone is an antibiotic which is utilized for curing a number of bacterial infections. The India ceftriaxone market is driven by surging population with urinary tract (UTI) and skin infections in India. Additionally, government initiatives for spreading awareness coupled with high investments for research activities by major market players are some other factors which is projected to bolster the market growth. Also, the medication is a popular drug choice for the treatment of bacterial meningitis which is further expected to boost the demand through FY2026.

The India ceftriaxone market is segmented based on dose, source, form, distribution channel, application, end user, company, and region. Based on form, the market can be segmented into intramuscular injection, intravenous injection, infusion, others. The intramuscular injection segment is expected to grow at a highest CAGR in the market over the next 5 years because intramuscular injections are used as an alternative to intravenous injections because some drugs are irritating to veins. Along with this, sometimes a suitable vein cannot be located, which is another major reason boosting its demand, thus estimated to drive the segmental growth in near future.

The major players operating in the India ceftriaxone market are Radicura Pharmaceuticals Pvt. Ltd, Wockhardt Limited (Taurus), Nectar Lifesciences Ltd., Qilu Pharmaceutical India Pvt. Ltd., Mankind Pharma Ltd., Fresenius Kabi India Pvt. Ltd., Virchow Healthcare Private Limited, Orchid Pharma Ltd., Ikon Remedies Pvt. Ltd., IPCA Laboratories Ltd, and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, portfolio expansions and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India ceftriaxone market from FY2016 to FY2019.
  • To estimate and forecast the market size of India ceftriaxone market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India ceftriaxone market based on dose, source, form, distribution channel, application, end user, company, and regional distribution.
  • To identify dominant region or segment in the India ceftriaxone market.
  • To identify drivers and challenges for India ceftriaxone market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India ceftriaxone market.
  • To identify and analyze the profile of leading players operating in India ceftriaxone market.
  • To identify key sustainable strategies adopted by market players in India ceftriaxone market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India ceftriaxone market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Ceftriaxone manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to ceftriaxone

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India ceftriaxone market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Ceftriaxone Market, By Dose:
    • 100 mg
    • 200 mg
    • 250 mg
    • 500 mg
    • Others
  • India Ceftriaxone Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Ceftriaxone Market, By Form:
    • Intramuscular Injection
    • Intravenous Injection
    • Infusion
    • Others
  • India Ceftriaxone Market, By Distribution Channel:
    • Online
    • Offline
  • India Ceftriaxone Market, By Application:
    • Endocarditis
    • Meningitis
    • Pneumonia
    • Bone and Joint Infections
    • Intra-Abdominal Infections
    • Skin Infections
    • Urinary Tract Infections
    • Gonorrhoea
    • Others
  • India Ceftriaxone Market, By End User:
    • Adult
    • Paediatric
  • India Ceftriaxone Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India ceftriaxone market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India ceftriaxone market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Ceftriaxone Market

4.    Executive Summary

5.    Manufacturing Ceftriaxone

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Ceftriaxone

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Ceftriaxone Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Dose (100 mg, 200 mg, 250 mg, 500 mg and Others)

7.2.2.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.3.     By Form (Intramuscular Injection, Intravenous Injection, Infusion, Others)

7.2.4.     By Distribution Channel (Online v/s Offline)

7.2.5.     By Application (Endocarditis, Meningitis, Pneumonia, Bone and Joint Infections, Intra-Abdominal Infections, Skin Infections, Urinary Tract Infections, Gonorrhoea, Others)

7.2.6.     By End User (Adult v/s Paediatric)

7.2.7.     By Region (North, East, South, West)

7.2.8.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Radicura Pharmaceuticals Pvt. Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Wockhardt Limited (Taurus)

14.1.3.  Nectar Lifesciences Ltd.

14.1.4.  Qilu Pharmaceutical India Pvt. Ltd.

14.1.5.  Mankind Pharma Ltd.

14.1.6.  Fresenius Kabi India Pvt. Ltd.

14.1.7.  Virchow Healthcare Private Limited

14.1.8.  Orchid Pharma Ltd.

14.1.9.  Ikon Remedies Pvt. Ltd.

14.1.10.                IPCA Laboratories Ltd.

15.  Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Frequently asked questions






Sakshi Bajaal

Business Consultant
Press Release

India Ceftriaxone Market to grow at a steady rate During the Forecast Period

Oct, 2020

Growing prevalence of bacterial infections is expected to drive the growth of India ceftriaxone market during the forecast period.